Organisation paid for research Program year 2025 Source: CMS Open Payments

JBR Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$6,045,720

371 payments

Through program year 2025, JBR Clinical Research LLC is reported as receiving $6,045,720 in research payments, across 371 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $768,450 62
2024 Research $1,401,606 16
2023 Research $1,174,228 44
2022 Research $1,516,303 127
2021 Research $809,448 94
2020 Research $105,153 18
2019 Research $270,533 10

Breakdown

Who paid Research payments · program years 2019–2025
  1. Bayer Healthcare LLC $2,428,744 26 payments
  2. Heron Therapeutics, Inc. $703,092 31 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $667,363 2 payments
  4. Moderna TX, Inc. $661,385 59 payments
  5. Sanofi Pasteur Inc. $520,868 59 payments
  6. Pfizer Inc. $444,490 69 payments
  7. GlaxoSmithKline, LLC. $277,181 74 payments
  8. American Regent $98,992 1 payment
  9. Organon LLC $98,172 25 payments
  10. Ocular Therapeutix, Inc. $42,997 8 payments
Studies the money was for Research payments · program years 2019–2025
  1. Project 22093 E2 Pivotal Dental Study $3,096,107 28 payments
  2. A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE $369,381 14 payments
  3. A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age $327,599 27 payments
  4. A Phase 3 Randomized Doubleblinded Placebocontrolled Trial to Evaluate the Efficacy and Safety of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy $300,092 45 payments
  5. Herniorrhaphy Study for Opioid Elimination $262,883 7 payments
  6. A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age $202,416 5 payments
  7. Immunogenicity and Safety of the First-in-Human SARS-CoV-2 mRNA Vaccine Formulation in Healthy Adults 18 Years of Age and Older $177,817 14 payments
  8. Phase 3B, Randomized, Observer-Blind. Multicenter Study to Assess the $151,598 48 payments
  9. MET41 A Randomized Study to Describe the Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $113,450 8 payments
  10. Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers $106,300 13 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $98,172 25 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record